A Pilot Study to assess Theragnostically Planned Liver Radiation with Functional DVH Analysis to Optimize Individualized Radiation Therapy
Ryan Rhome, MD
Primary Investigator
Brief description of study
The purpose of this study is to compare radiation treatment plans that are designed for patients with liver cancer.
Detailed description of study
One treatment plan will be created using routine procedures and scans normally performed for radiation treatment planning. The other treatment plan will be created using routine procedures with the addition of two imaging scans; a HIDA (Hepatobiliary Iminodiacetic Acid) scan and an MRI (Magnetic Resonance Imaging) scan. This study will evaluate if adding these imaging scans to treatment planning can reduce the amount of radiation to healthy liver tissue during treatment.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: liver cancer,Hepatocellular Carcinoma,Cholangiocarcinoma
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria
Primary liver malignancy including hepatocellular carcinoma (HCC) or cholangiocarcinoma
Subjects must have a Child-Turcotte-Pugh (CTP) score less than or equal to 7
Exclusion Criteria
Subject who are pregnant or planning to become pregnant during the study
No more than 3 lesions can be treated. Total diameter of all lesions must be less than or equal to 6 cm
Prior radiation treatment to the upper abdomen
Active infection, active upper GI ulceration or hemorrhage, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
